Exploring practical experience with different treatments in NSCLC patients with MET-deregulated: a retrospective analysis from the real world
Abstract Background Mesenchymal to epithelial transition factor (MET) dysregulation in non-small-cell-lung-cancer (NSCLC) is understudied, with scant data on treatment outcomes. Methods We retrospectively examined 160 NSCLC patients: 125 with primary MET mutations (further classified into MET exon 1...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Pulmonary Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12890-024-03437-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!